Epidemic meningococcal meningitis, Cameroon

Emerging Infectious Diseases

Volumn 17, Issue 11, 2011, Pages 2070-2072

  Massenet, D ^a   Vohod, D ^b   Hamadicko, H ^c   Caugant, D A ^d  

^a CENTRE PASTEUR DU CAMEROUN   (Cameroon)

^b Hôpital Régional de Ngaoundéré   (Cameroon)

^c Délégation Régionale de la Santé Publique ^*  (Cameroon)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM; CHLORAMPHENICOL; COTRIMOXAZOLE;

ADOLESCENT; ADULT; AGGLUTINATION TEST; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATE; BLOOD GROUP TYPING; CAMEROON; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; EPIDEMIC; EPIDEMIC MENINGITIS; FEMALE; GRAM STAINING; HUMAN; LETTER; LUMBAR PUNCTURE; MALE; NEISSERIA MENINGITIDIS;

EID: 84930482694     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1711.110468     Document Type: Letter

References (7)

1. Lapeyssonnie L. Cerebrospinal meningitis in Africa [in French]. Bull World Health Organ. 1963;28(Suppl):1-114.
2. Molesworth AM, Thomson MC, Connor SJ, Cresswell MP, Morse AP, Shears P, et al. Where is the meningitis belt? De-fi ning an area at risk of epidemic meningitis in Africa. Trans R Soc Trop Med Hyg. 2002;96:242-9. doi:10.1016/S0035-9203(02)90089-1
3. Cuevas LE, Jeanne I, Molesworth A, Bell M, Savory EC, Connor SJ, et al. Risk mapping and early warning systems for the control of meningitis in Africa. Vaccine. 2007;25(Suppl 1):A12-7. doi:10.1016/j. vaccine.2007.04.034
4. Massenet D, Inrombe J. Impact of the biological monitoring of cerebrospinal meningitis on the notifi cation of cases in North Cameroon [in French]. Rev Epidemiol Sante Publique. 2009;57:451-3. doi:10.1016/j.respe.2009.08.010
5. Massenet D, Inrombe J, Mevoula DE, Nicolas P. Serogroup W135 meningococ-cal meningitis, northern Cameroon, 2007- 2008. Emerg Infect Dis. 2009;15:340-2. doi:10.3201/eid1502.080988
6. Riou JY, Djibo S, Sangare L, Lombart JP, Fagot P, Chippaux JP, et al. A predictable comeback: the second pandemic of infections caused by Neisseria meningitidis serogroup A subgroup III in Africa, 1995. Bull World Health Organ. 1996;74:181-7.
7. Cunin P, Fonkoua MC, Kollo B, Bedifeh BA, Bayanak P, Martin PM, et al. Neis-seria meningitidis outside meningitis belt in southwest Cameroon. Emerg Infect Dis. 2003;9:1351-3.